2-hydroxyisobutyryl-HIST1H4A (K5) Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship your orders within 1-3 business days of receipt. Delivery times may vary depending on the purchase method and location. For specific delivery timelines, please contact your local distributor.
Synonyms
Histone H4, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4, H4/A H4FA, H4/I H4FI, H4/G H4FG, H4/B H4FB, H4/J H4FJ, H4/C H4FC, H4/H H4FH, H4/M H4FM, H4/E H4FE, H4/D H4FD, H4/K H4FK, H4/N H4F2 H4FN HIST2H4, H4/O H4FO
Target Names
HIST1H4A
Uniprot No.

Target Background

Function
Histone H4 is a core component of the nucleosome, the fundamental unit of chromatin. Nucleosomes are responsible for packaging and compacting DNA, thus limiting access to cellular machinery that requires DNA as a template. Histones play a pivotal role in regulating transcription, DNA repair, DNA replication, and maintaining chromosomal stability. The accessibility of DNA is modulated by a complex system of post-translational modifications of histones, often referred to as the histone code, and by nucleosome remodeling.
Gene References Into Functions
  1. Studies have shown that PP32 and SET/TAF-Ibeta proteins inhibit HAT1-mediated H4 acetylation. PMID: 28977641
  2. Research suggests that post-translational modifications of histones, specifically trimethylation of lysine 36 in H3 (H3K36me3) and acetylation of lysine 16 in H4 (H4K16ac), play roles in DNA damage repair. Notably, H3K36me3 promotes H4K16ac upon DNA double-strand break, and this process requires the involvement of SETD2, LEDGF, and KAT5 (SETD2 = SET domain containing 2; LEDGF = lens epithelium-derived growth factor; KAT5 = lysine acetyltransferase 5). PMID: 28546430
  3. Data indicates that the Omomyc protein co-localizes with the proto-oncogene protein c-myc (c-Myc), protein arginine methyltransferase 5 (PRMT5), and histone H4 H4R3me2s-enriched chromatin domains. PMID: 26563484
  4. H4K12ac is regulated by estrogen receptor-alpha and is linked to BRD4 function and inducible transcription. PMID: 25788266
  5. Systemic lupus erythematosus appears to be associated with an imbalance in histone acetyltransferases and histone deacetylase enzymes, favoring pathological H4 acetylation. PMID: 25611806
  6. Sumoylated human histone H4 prevents chromatin compaction by inhibiting long-range internucleosomal interactions. PMID: 25294883
  7. Acetylation at lysine 5 of histone H4 is associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus. PMID: 25283865
  8. An increase in histone H4 acetylation caused by hypoxia in human neuroblastoma cell lines corresponds to increased levels of N-myc transcription factor in these cells. PMID: 24481548
  9. Data indicate that G1-phase histone assembly is restricted to CENP-A and H4. PMID: 23363600
  10. This study focused on the distribution of a specific histone modification, namely H4K12ac, in human sperm and characterized its specific enrichment sites in promoters throughout the whole human genome. PMID: 22894908
  11. SRP68/72 heterodimers are major nuclear proteins whose binding of the histone H4 tail is inhibited by H4R3 methylation. PMID: 23048028
  12. TNF-alpha inhibition of AQP5 expression in human salivary gland acinar cells is attributed to an epigenetic mechanism involving suppression of acetylation of histone H4. PMID: 21973049
  13. Our findings suggest that global histone H3 and H4 modification patterns are potential markers of tumor recurrence and disease-free survival in non-small cell lung cancer. PMID: 22360506
  14. HAT1 differentially impacts nucleosome assembly of H3.1-H4 and H3.3-H4. PMID: 22228774
  15. Phosphorylation of histone H4 Ser 47, catalyzed by the PAK2 kinase, promotes nucleosome assembly of H3.3-H4 and inhibits nucleosome assembly of H3.1-H4 by increasing the binding affinity of HIRA to H3.3-H4 and reducing the association of CAF-1 with H3.1-H4. PMID: 21724829
  16. The imatinib-induced hemoglobinization and erythroid differentiation in K562 cells are associated with global histone H4 modification. PMID: 20949922
  17. Our findings reveal the molecular mechanisms by which the DNA sequences within specific gene bodies are sufficient to nucleate the monomethylation of histone H4 lysine 200, which, in turn, reduces gene expression by half. PMID: 20512922
  18. Expression is downregulated by zinc and upregulated by docosahexaenoate in a neuroblastoma cell line. PMID: 19747413
  19. Low levels of histone acetylation are associated with the development and progression of gastric carcinomas, possibly through alteration of gene expression. PMID: 12385581
  20. Overexpression of MTA1 protein and acetylation levels of histone H4 protein are closely related. PMID: 15095300
  21. Peptidylarginine deiminase 4 (PAD4) regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. Data suggests that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histones. PMID: 15345777
  22. The lack of biotinylation of K12 in histone H4 is an early signaling event in response to double-strand breaks. PMID: 16177192
  23. Incorporation of acetylated histone H4-K16 into nucleosomal arrays inhibits the formation of compact 30-nanometer-like fibers and impedes the ability of chromatin to form cross-fiber interactions. PMID: 16469925
  24. Apoptosis is associated with global DNA hypomethylation and histone deacetylation events in leukemia cells. PMID: 16531610
  25. BTG2 contributes to retinoic acid activity by favoring differentiation through a gene-specific modification of histone H4 arginine methylation and acetylation levels. PMID: 16782888
  26. There is a relationship between histone H4 modification, epigenetic regulation of BDNF gene expression, and long-term memory for extinction of conditioned fear. PMID: 17522015
  27. The H4 tail and its acetylation play novel roles in mediating the recruitment of multiple regulatory factors that can change chromatin states for transcription regulation. PMID: 17548343
  28. Brd2 bromodomain 2 is monomeric in solution and dynamically interacts with H4-AcK12. Additional secondary elements in the long ZA loop may be a common characteristic of BET bromodomains. PMID: 17848202
  29. Spermatids Hypac-H4 impairment in mixed atrophy was not further deteriorated by AZFc region deletion. PMID: 18001726
  30. The SET8 and PCNA interaction couples H4-K20 methylation with DNA replication. PMID: 18319261
  31. H4K20 monomethylation and PR-SET7 are important for L3MBTL1 function. PMID: 18408754
  32. High expression of acetylated H4 is more common in aggressive than indolent cutaneous T-cell lymphoma. PMID: 18671804
  33. Our findings indicate an important role of histone H4 modifications in bronchial carcinogenesis. PMID: 18974389
  34. Results indicate that, through acetylation of histone H4 K16 during S-phase, early replicating chromatin domains acquire the H4K16ac-K20me2 epigenetic label, which persists on the chromatin throughout mitosis and is deacetylated in early G1-phase of the next cell cycle. PMID: 19348949
  35. Acetylated H4 is overexpressed in diffuse large B-cell lymphoma and peripheral T-cell lymphoma relative to normal lymphoid tissue. PMID: 19438744
  36. The release of histone H4 by holocrine secretion from the sebaceous gland may play a significant role in innate immunity. PMID: 19536143
  37. Histone modification, including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4, may be involved in CD11b transcription during HL-60 leukemia cells reprogramming to terminal differentiation. PMID: 19578722
  38. A role of Cdk7 in regulating elongation is further suggested by enhanced histone H4 acetylation and diminished histone H4 trimethylation on lysine 36—two marks of elongation—within genes when the kinase was inhibited. PMID: 19667075
  39. Data showed the dynamic fluctuation of histone H4 acetylation levels during mitosis, as well as acetylation changes in response to structurally distinct histone deacetylase inhibitors. PMID: 19805290
  40. Data directly implicate BBAP in the monoubiquitylation and additional posttranslational modification of histone H4 and an associated DNA damage response. PMID: 19818714

Show More

Hide All

Database Links

HGNC: 4781

OMIM: 142750

KEGG: hsa:121504

STRING: 9606.ENSP00000367034

UniGene: Hs.143080

Involvement In Disease
Chromosomal aberrations involving HISTONE H4 is a cause of B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;6)(q27;p21), with BCL6.
Protein Families
Histone H4 family
Subcellular Location
Nucleus. Chromosome.

Q&A

Basic Research Questions

  • What is 2-hydroxyisobutyryl-HIST1H4A (K5) antibody and what does it detect?

    The 2-hydroxyisobutyryl-HIST1H4A (K5) antibody is a rabbit polyclonal antibody specifically designed to detect the 2-hydroxyisobutyrylation modification at lysine 5 of histone H4 in human samples. This antibody recognizes a peptide sequence around the site of 2-hydroxyisobutyryl-Lys (5) derived from Human Histone H4. It is purified by antigen affinity chromatography and is typically supplied in a buffer containing 0.01 M PBS (pH 7.4), 0.03% Proclin-300, and 50% glycerol . The antibody enables researchers to study this specific post-translational modification (PTM) which has been implicated in transcriptional regulation and other epigenetic processes.

  • What applications is the 2-hydroxyisobutyryl-HIST1H4A (K5) antibody validated for?

    The 2-hydroxyisobutyryl-HIST1H4A (K5) antibody has been validated for multiple laboratory applications including:

    • ELISA (Enzyme-Linked Immunosorbent Assay)

    • Western Blotting (WB)

    • Immunofluorescence (IF)

    • Immunocytochemistry (ICC)

    When designing experiments, it's important to empirically determine optimal dilutions for each application as these may vary depending on sample type, detection method, and experimental conditions. For Western blotting applications, researchers should expect to detect a band at approximately 11 kDa, which corresponds to the molecular weight of histone H4 .

  • How does 2-hydroxyisobutyrylation differ from other histone modifications?

    2-hydroxyisobutyrylation (Khib) is structurally and mechanistically distinct from other histone acylations such as acetylation. While lysine acetylation and 2-hydroxyisobutyrylation both occur on lysine residues, they have:

    • Different chemical structures: 2-hydroxyisobutyrylation has a larger and more complex modification group

    • Distinct genomic distributions: Studies show Khib has unique patterns compared to acetylation marks

    • Different regulatory enzymes: While some histone deacetylases (HDAC 1-3, Rpd3p, and Hos3p) may function as de-2-hydroxyisobutyrylation enzymes, the regulation differs

    • Unique functional impacts: Khib can affect protein-protein interactions differently than acetylation

    Research has shown that histone H4K5 2-hydroxyisobutyrylation, unlike acetylation, can abolish the interaction between the first bromodomain of Brdt and the histone H4 tail, indicating distinct functional consequences .

  • What is the biological significance of histone H4K5 2-hydroxyisobutyrylation?

    Histone H4K5 2-hydroxyisobutyrylation represents an important epigenetic modification with several biological functions:

    • Transcriptional regulation: It is associated with active gene transcription

    • Chromatin structure modulation: It affects the interaction between histones and DNA

    • Metabolic sensing: Research indicates it is regulated by glucose availability and cellular metabolism

    • Cell differentiation: It shows dynamic changes during male germ cell differentiation

    Studies have demonstrated that 2-hydroxyisobutyrylation of H4K5 can specifically prevent binding of bromodomain-containing proteins like Brdt, suggesting a role in controlling protein recruitment to chromatin. This contrasts with H4K8 2-hydroxyisobutyrylation, which does not abolish such interactions , highlighting the position-specific effects of this modification.

Advanced Research Questions

  • How does the 2-hydroxyisobutyryl-HIST1H4A (K5) antibody specificity compare to antibodies for other H4 modifications?

    When evaluating antibody specificity for histone PTMs, cross-reactivity is a critical concern. The 2-hydroxyisobutyryl-HIST1H4A (K5) antibody demonstrates high specificity for its target modification compared to other H4 modification antibodies. Research has shown:

    AntibodyTarget ModificationCross-reactivity with other PTMsApplicationsReference
    Anti-H4K5hib2-hydroxyisobutyrylation at K5Minimal cross-reactivity with H4K5acWB, ELISA, IF/ICC
    Anti-H4K5acAcetylation at K5Some cross-reactivity when K8 is acetylatedWB, ChIP-seq
    Anti-H4K5bhbβ-hydroxybutyrylation at K5Minimal cross-reactivity with other K5 modificationsWB
    Anti-H4K8hib2-hydroxyisobutyrylation at K8Minimal cross-reactivity with H4K8acWB, ICC/IF

    The CMA405 antibody for H4K5ac shows a unique property of only reacting with K5ac when the neighboring K8 is unacetylated, allowing researchers to distinguish between newly assembled H4 (diacetylated at K5 and K12) and hyperacetylated H4 (where both K5 and K8 are acetylated) . Similar detailed characterization for the 2-hydroxyisobutyryl-HIST1H4A (K5) antibody is essential for accurate interpretation of experimental results.

  • What are the optimal protocols for using 2-hydroxyisobutyryl-HIST1H4A (K5) antibody in ChIP-seq experiments?

    For successful ChIP-seq experiments using 2-hydroxyisobutyryl-HIST1H4A (K5) antibody, consider the following methodological approach:

    1. Sample preparation:

      • Cross-link cells with 1% formaldehyde for 10 minutes at room temperature

      • Quench with 0.125 M glycine for 5 minutes

      • Harvest cells and wash with cold PBS containing protease inhibitors

    2. Chromatin preparation:

      • Lyse cells in appropriate buffers containing protease inhibitors

      • Sonicate chromatin to fragments of 200-500 bp (optimize sonication time)

      • Confirm fragment size by agarose gel electrophoresis

    3. Immunoprecipitation:

      • Pre-clear chromatin with protein A/G beads

      • Incubate chromatin with 2-5 μg of antibody overnight at 4°C

      • Add protein A/G beads and incubate for 2-3 hours

      • Wash extensively with increasingly stringent buffers

    4. DNA recovery and library preparation:

      • Reverse cross-links at 65°C overnight

      • Purify DNA using standard methods

      • Prepare sequencing library according to platform requirements

    5. Controls and validation:

      • Include input control (non-immunoprecipitated chromatin)

      • Include IgG control for non-specific binding

      • Validate enrichment by qPCR before sequencing

      • Consider using spike-in controls for quantitative comparisons

    Based on studies with similar histone modification antibodies, surface plasmon resonance (SPR) measurements are recommended to determine antibody affinity for the target epitope, and ChIP-qPCR should be performed to confirm significant enrichment at selected genomic regions before proceeding to genome-wide sequencing .

  • How do cellular metabolic states affect histone H4K5 2-hydroxyisobutyrylation levels?

    Cellular metabolism has profound effects on histone 2-hydroxyisobutyrylation levels, particularly at H4K5. Research has established several key relationships:

    • Glucose availability: Studies in yeast have shown that histone 2-hydroxyisobutyrylation levels are regulated by glucose concentration, with the modification responding to changes in glycolytic flux

    • Metabolic intermediates: The cellular levels of 2-hydroxyisobutyrate and 2-hydroxyisobutyryl-CoA, which serve as metabolic precursors for this modification, directly impact the extent of histone 2-hydroxyisobutyrylation

    • Nutrient stress response: In plants, histone Khib works together with H3K23ac to regulate genes involved in starch and sucrose metabolism, pentose and glucuronate interconversions, and phenylpropanoid biosynthesis, helping to fine-tune plant response to dark-induced starvation

    • Enzyme regulation: Both writers (acetyltransferases like Esa1p and TIP60) and erasers (deacetylases like HDAC1-3, Rpd3p, and Hos3p) of this modification are influenced by metabolic states

    Experimental data from yeast studies demonstrated that proteins involved in glycolysis and electron transport chain complexes are differentially 2-hydroxyisobutyrylated under varying glucose concentrations, suggesting a broader metabolic regulatory network beyond histones .

  • What is the cross-talk between histone H4K5 2-hydroxyisobutyrylation and other histone modifications?

    The interplay between histone H4K5 2-hydroxyisobutyrylation and other histone modifications reveals complex regulatory mechanisms:

    1. Spatial relationships:

      • In Arabidopsis, histone Khib does not overlap with frequently modified N-tail lysines such as H3K4, H3K9, and H4K8

      • H4K5 2-hydroxyisobutyrylation and acetylation can be mutually exclusive at the same residue

    2. Functional interactions:

      • H4K5 2-hydroxyisobutyrylation abolishes the binding of Brdt to histone H4, while H4K8 2-hydroxyisobutyrylation only slightly affects this interaction

      • In plants, co-enrichment of histone Khib and H3K23ac correlates with high gene expression levels

    3. Enzymatic regulation:

      • Some histone deacetylases (HDACs) can remove both acetyl and 2-hydroxyisobutyryl groups

      • In plants, HDA6 and HDA9 are involved in removing histone Khib

    4. Competitive modifications:

      • Studies on H4K5 indicate complex interactions between different types of acylations (acetylation, propionylation, butyrylation, crotonylation, and 2-hydroxyisobutyrylation)

      • Research with PRMTs (protein arginine methyltransferases) showed that H4K5 2-hydroxyisobutyrylation decreased arginine methylation by PRMT1, PRMT3, and PRMT8, demonstrating cross-regulation between different types of modifications

    This cross-talk creates a complex "histone code" where combinations of modifications fine-tune the cellular response to various stimuli.

  • How can I troubleshoot non-specific binding or weak signals when using the 2-hydroxyisobutyryl-HIST1H4A (K5) antibody?

    When encountering issues with 2-hydroxyisobutyryl-HIST1H4A (K5) antibody performance, consider these methodological troubleshooting approaches:

    For weak signals:

    1. Optimization of antibody concentration:

      • Perform a titration experiment using 1:250, 1:1000, and 1:4000 dilutions to identify optimal concentration

      • For ICC/IF applications, starting dilutions of 1:7.5 to 1:15 have been effective for similar histone modification antibodies

    2. Enhancement of target accessibility:

      • Increase cell permeabilization time (up to 15 minutes with 0.3% Triton X-100)

      • For Western blots, ensure complete protein denaturation and optimize transfer conditions for histones

    3. Signal amplification:

      • Consider using a biotin-streptavidin system for detection

      • For ICC, an HRP-conjugated SP system may provide enhanced sensitivity

    For non-specific binding:

    1. Blocking optimization:

      • Use 10% normal goat serum for ICC/IF applications

      • For Western blots, 5% BSA in TBST is often more effective than milk for phospho-specific antibodies

    2. Validation controls:

      • Include peptide competition assays to confirm specificity

      • Compare signals in cells treated with HDAC inhibitors (e.g., sodium butyrate) versus untreated cells

      • Include appropriate negative controls (samples without the modification)

    3. Cross-reactivity testing:

      • Test antibody against synthetic peptides bearing similar modifications (acetylation, butyrylation, etc.)

      • Consider multiplex assays like dCypher Luminex to simultaneously evaluate antibody specificity against multiple modified histone forms

    For robust quantitative comparisons, normalize data to total H4 levels and include multiple biological replicates to account for variability in modification levels.

  • What emerging techniques are being developed to study histone H4K5 2-hydroxyisobutyrylation dynamics?

    Several cutting-edge techniques are advancing our understanding of histone H4K5 2-hydroxyisobutyrylation dynamics:

    1. Site-specific incorporation technologies:

      • Amber suppression-mediated strategy allows site-specific incorporation of ε-N-2-Hydroxyisobutyryl-lysine into proteins in bacteria and mammalian cells

      • This approach enables precise control over modification placement for functional studies

    2. Multicolor immunofluorescence:

      • Direct labeling of modification-specific antibodies enables simultaneous visualization of multiple histone modifications in single cells

      • This technique allows temporal tracking of modification dynamics during the cell cycle

    3. Mass spectrometry-based proteomics:

      • Antibody-based affinity enrichment combined with nano-HPLC/MS/MS analysis of 2-hydroxyisobutyrylation peptides

      • This approach has identified thousands of 2-hydroxyisobutyryl lysine sites across diverse proteomes

    4. CRISPR-based epigenome editing:

      • Fusion of catalytic domains of putative 2-hydroxyisobutyrylation writers or erasers to catalytically inactive Cas9 (dCas9)

      • This allows targeted modulation of H4K5hib at specific genomic loci

    5. Stable isotope labeling approaches:

      • SILAC (Stable Isotope Labeling by Amino Acids in Cell Culture) combined with mass spectrometry to quantitatively track changes in 2-hydroxyisobutyrylation in response to metabolic alterations

      • This approach has revealed that 2-hydroxyisobutyrylation levels are differentially regulated under different glucose concentrations

    6. Surface plasmon resonance (SPR):

      • Used to measure the affinities of antibodies for their respective targets

      • Enables comparison of binding affinities between different histone modification antibodies

    These emerging technologies provide researchers with powerful tools to investigate the dynamic regulation and functional consequences of histone H4K5 2-hydroxyisobutyrylation in diverse biological contexts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.